
News|Articles|December 15, 2024
MHE Week in Review – Humira Dose De-escalation, 5 Drugs With Unsupported Price Increases and More
Author(s)Logan Lutton
Here’s what you missed this week on Managed Healthcare Executive.
Advertisement
Each Sunday we feature a highlight reel of various articles posted on our website that week.
We’ll be back on Monday morning with more fresh content!
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
PBM reform. It has finally happened
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
ACHP announces new funding to elevate patient voices in diabetes research
4
Melanoma diagnoses projected to rise in 2026
5























